Markets:

Overview

News

Currencies

International

Treasuries

Vera Therapeutics, Inc. - Class A Common Stock (NQ:VERA)

42.29 -1.76 (-4.00%)

Streaming Delayed Price Updated: 11:51 AM EST, Feb 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Vera Therapeutics, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 Next >

Why Vera Therapeutics Stock Zoomed Higher Today ↗

January 07, 2026

The company has a fine chance of commercializing its leading investigational drug in the near future.

Via The Motley Fool

Why Vera Therapeutics Stock Rocked the Market on Tuesday ↗

December 02, 2025

A competitor recently earned FDA approval, but this drug is reportedly going to be pricey.

Via The Motley Fool

Why Vera Therapeutics Stock Crushed it Today ↗

November 26, 2025

If all goes well, the company will have a drug on the market that could bring in billions of dollars in revenue.

Via The Motley Fool

Get insights into the top gainers and losers of Tuesday's after-hours session. ↗

November 25, 2025

After the closing bell on Tuesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.

Via Chartmill

10 Health Care Stocks Whale Activity In Today's Session ↗

November 05, 2025

Via Benzinga

VERA THERAPEUTICS INC (NASDAQ:VERA) Reports Q3 2025 Earnings, Misses EPS Estimates Amid Key Clinical Progress ↗

November 05, 2025

Vera Therapeutics posts Q3 2025 financial results with a widened loss, but key clinical progress for atacicept in IgAN and an upcoming BLA submission drive investor focus.

Via Chartmill

Topics Earnings

Capricorn Fund Loads Up on Phreesia (PHR) With a 484,000 Share Purchase ↗

October 27, 2025

Capricorn Fund Loads Up on Phreesia (PHR) With a 484,000 Share Purchase

Via The Motley Fool

Capricorn Buys New Stake in Ionis Pharmaceuticals (IONS) With 163,000 Shares ↗

October 20, 2025

Via The Motley Fool

Vera Therapeutics' Lead Kidney Drug Poised For 2026 Launch In Multi-Billion-Dollar Market ↗

October 16, 2025

Bank of America initiates coverage on Vera Therapeutics, citing strong potential for atacicept, its kidney treatment.

Via Benzinga

This Celestica Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗

October 16, 2025

Via Benzinga

6 Stocks Goldman Sachs Says Are Poised For Potential Acquisition In Next 12 Months — Including A Huge 200% Winner ↗

September 30, 2025

Goldman Sachs has highlighted six stocks that have a high probability of being acquisition targets in the next year.

Via Benzinga

Vera (VERA) Q2 Net Loss Widens 127% ↗

August 06, 2025

Via The Motley Fool

This AvalonBay Communities Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Monday ↗

August 04, 2025

Via Benzinga

Get insights into the top gainers and losers of Friday's pre-market session. ↗

July 18, 2025

The US market is yet to commence its session on Friday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.

Via Chartmill

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

July 18, 2025

Via Benzinga

Analysts Can't Get Enough of These Little-Known Biopharma Stocks

June 12, 2025

Three relatively unknown biopharma firms receive near-unanimous approval from analysts for their promising drug candidates in development.

Via MarketBeat

10 Health Care Stocks With Whale Alerts In Today's Session ↗

June 12, 2025

Via Benzinga

Which stocks are moving on Friday? ↗

June 06, 2025

Let's have a look at what is happening on the US markets one hour before the close of the markets on Friday. Below you can find the top gainers and losers in today's session.

Via Chartmill

12 Health Care Stocks Moving In Friday's Intraday Session ↗

June 06, 2025

Via Benzinga

Let's take a look at the stocks that are in motion in today's session. ↗

June 06, 2025

Wondering how the US markets performed in the middle of the day on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.

Via Chartmill

Crude Oil Gains 2%; ABM Industries Shares Plunge After Q2 Results ↗

June 06, 2025

Via Benzinga

Dow Jumps Over 500 Points; Nonfarm Payrolls Top Estimates ↗

June 06, 2025

Via Benzinga

Topics Stocks

Discover the top movers in Friday's pre-market session. ↗

June 06, 2025

Discover the top movers in Friday's pre-market session and stay informed about market dynamics.

Via Chartmill

Lululemon Cuts Earnings Forecast, Joins DocuSign, Samsara And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

June 06, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

June 06, 2025

Via Benzinga

Why Rent the Runway Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket ↗

June 06, 2025

Via Benzinga

Vera Therapeutics Enters $500M Credit Facility As It Nears FDA Filing For Kidney Disease Drug: Retail Sees Stock Touching $40 ↗

June 03, 2025

The new credit facility features a lower interest rate, increasing capital availability and financial flexibility, the company stated.

Via Stocktwits

Here are the top movers in Monday's session. ↗

June 02, 2025

Wondering how the US markets performed one hour before the close of the markets on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.

Via Chartmill

12 Health Care Stocks Moving In Monday's Intraday Session ↗

June 02, 2025

Via Benzinga

Nasdaq Edges Higher; ISM Manufacturing PMI Falls In May ↗

June 02, 2025

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Vera Therapeutics, Inc. - Class A Common Stock (NQ:VERA)

Headline News about Vera Therapeutics, Inc. - Class A Common Stock

Starting at $3.75/week.

Subscribe Today